Skip to content

Prevalence and Risk Factors of Hyperkalemia in Non-Dialysis Chronic Kidney Disease Patients in a Community-Based Primary Care Setting

Prevalence and Risk Factors of Hyperkalemia in Non-Dialysis Chronic Kidney Disease Patients in a Community-Based Primary Care Setting

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500101082
Enrollment
Unknown
Registered
2025-04-18
Start date
2025-04-21
Completion date
Unknown
Last updated
2025-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperkalemia

Interventions

N/A:N/A

Sponsors

Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged 18 years or older with stable vital signs, specifically defined as: (1) Body temperature: 36.0°C–38.0°C; (2) Pulse: 50–120 beats/min; (3) Respiratory rate: 10–24 breaths/min; (4) Blood pressure: Systolic blood pressure >=90 mmHg and diastolic blood pressure >=60 mmHg. 2. Willing to participate in the study and sign the informed consent form. 3. Hematocrit (Hct) level between 25% and 60%. 4. Confirmed diagnosis of chronic kidney disease (CKD).

Exclusion criteria

Exclusion criteria: 1. Patients in the unstable phase of acute cardiovascular or cerebrovascular diseases (e.g., acute cerebral infarction, cerebral hemorrhage, or acute coronary syndrome). 2. Patients in the unstable phase of severe acute diabetic complications (e.g., diabetic ketoacidosis or hyperosmolar hyperglycemic coma). 3. Patients currently in the acute kidney injury (AKI) stage. 4. Patients who have started renal replacement therapy. 5. Pregnant or breastfeeding women. 6. Patients currently participating in or who have participated in other clinical trials within the past six months. 7. Patients unable to understand verbal or written instructions, including informed consent content. 8. Patients unable to cooperate with the study procedures. 9. Other conditions deemed unsuitable for participation in this clinical trial by the investigator.

Design outcomes

Secondary

MeasureTime frame
Blood Glucose;Creatinine;Uric Acid;Hemoglobin;

Primary

MeasureTime frame
Blood Potassium;Area under ROC curve;sensitivity;specificity;

Countries

China

Contacts

Public ContactXiujuan Zang

Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

zangxiujuan@shsmu.edu.cn+86 189 1828 9268

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026